Table 2.
Results of situation analysis.
| Variables | Number (n) | Percentage (%) | |||
|---|---|---|---|---|---|
| Type of private healthcare facilities | |||||
| Hospital | 5 | 56% | |||
| Non-hospital | 4 | 44% | |||
| Immunization service | |||||
| Per day | Per month | Per day | Per month | Per day | Per month |
| 3–6 h | <25 days | 4 | 5 | 44% | 56% |
| >6 h | > = 25 days | 5 | 4 | 56% | 44% |
| Staffs in vaccination unit | |||||
| Number of staffs | Trained staffs by MoH | Number of staffs | Trained staffs by MoH | Number of staffs | Trained staffs by MoH |
| <6 staffs | <6 staffs | 3 | 6 | 33% | 67% |
| 6–10 staffs | 6–10 staffs | 3 | 3 | 33% | 33% |
| >10 staffs | >10 staffs | 3 | 0 | 33% | 0% |
| Guideline for immunization services | |||||
| Using guideline | Type of guideline | Using guideline | Type of guideline | Using guideline | Type of guideline |
| No | Internal guideline | 3 | 4 | 33% | 67% |
| Yes | MoH’s guideline | 6 | 2 | 67% | 33% |
| Vaccine availability | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MR | BCG | Polio | Penta | PCV | IPV | HepB | MR | BCG | Polio | Penta | PCV | IPV | HepB | MR | BCG | Polio | Penta | PCV | IPV | HepB |
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | 8 | 9 | 9 | 9 | 8 | 6 | 9 | 89% | 100% | 100% | 100% | 89% | 67% | 100% |
| No | No | No | No | No | No | No | 1 | 0 | 0 | 0 | 1 | 3 | 0 | 11% | 0% | 0% | 0% | 11% | 33% | 0% |
| Vaccine stock out in the last 12 months | ||||||||||||||||||||
| MR | BCG | Polio | Penta | PCV | IPV | HepB | MR | BCG | Polio | Penta | PCV | IPV | HepB | MR | BCG | Polio | Penta | PCV | IPV | HepB |
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | 2 | 4 | 3 | 3 | 2 | 2 | 0 | 22% | 44% | 33% | 33% | 22% | 22% | 0% |
| No | No | No | No | No | No | No | 7 | 5 | 6 | 6 | 7 | 7 | 9 | 78% | 56% | 67% | 67% | 78% | 78% | 100% |
| Vaccine procurement | ||||||||||||||||||||
| MR | BCG | Polio | Penta | PCV | IPV | HepB | MR | BCG | Polio | Penta | PCV | IPV | HepB | MR | BCG | Polio | Penta | PCV | IPV | HepB |
| SP | SP | SP | SP | SP | SP | SP | 2 | 2 | 2 | 2 | 6 | 5 | 5 | 22% | 22% | 22% | 22% | 67% | 56% | 56% |
| GP | GP | GP | GP | GP | GP | GP | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 11% | 11% | 11% | 11% | 0% | 11% | 0% |
| C | C | C | C | C | C | C | 6 | 6 | 6 | 6 | 3 | 3 | 4 | 67% | 67% | 67% | 67% | 33% | 33% | 44% |
| Equipment | ||
|---|---|---|
| Cold box/vaccine carrier with ice packs | ||
| Yes | 9 | 100% |
| No | 0 | 0% |
| Refrigerator | ||
| Yes | 9 | 100% |
| No | 0 | 0% |
| Sharp container | ||
| Yes | 7 | 78% |
| No | 2 | 22% |
| Single use standard/auto disposable syringe | ||
| Yes | 8 | 89% |
| No | 1 | 11% |
| Continuous temperature monitoring device | ||
| Yes | 9 | 100% |
| No | 0 | 0% |
| Energy source and power supply | ||
| Yes | 7 | 78% |
| No | 2 | 22% |
| Immunization card | ||
| Yes | 9 | 100% |
| No | 0 | 0% |
MoH, Ministry of Health; MR, Measles Rubella; BCG, Bacillus Calmette–Guérin/TB vaccine; PCV, Pneumococcal Conjugate Vaccine; IPV, Inactivated Poliovirus Vaccine; HepB, Hepatitis B; SP, self-procurement; GP, government program; and C, combination of self-procurement and government program.